New Delhi: Anti-Müllerian Hormone (AMH), widely used to assess ovarian reserve, may not accurately reflect reproductive potential in women with cancer, particularly those with systemic inflammation, according to findings presented at the 2026 Annual Congress of the International Society of Gynecological Endocrinology (ISGE). Fertility Preservation Gains Urgency As cancer survival…
RamRajya News
Heralding RamRajya in Bharat